Literature DB >> 33666668

[Localised prostate cancer: radical prostatectomy or deferred treatment strategy].

Angelika Borkowetz1,2.   

Abstract

Entities:  

Year:  2021        PMID： 33666668     DOI： 10.1007/s00120-021-01482-z

Source DB:  PubMed          Journal:  Urologe A        ISSN： 0340-2592            Impact factor:   0.639


× No keyword cloud information.
  10 in total

1.  Active Surveillance for Prostate Cancer in a Real-life Cohort: Comparing Outcomes for PRIAS-eligible and PRIAS-ineligible Patients.

Authors:  Timo F W Soeterik; Harm H E van Melick; Lea M Dijksman; Douwe H Biesma; J Alfred Witjes; Jean-Paul A van Basten
Journal:  Eur Urol Oncol       Date:  2018-05-15

Review 2.  Active surveillance for prostate cancer: a systematic review of clinicopathologic variables and biomarkers for risk stratification.

Authors:  Stacy Loeb; Sophie M Bruinsma; Joseph Nicholson; Alberto Briganti; Tom Pickles; Yoshiyuki Kakehi; Sigrid V Carlsson; Monique J Roobol
Journal:  Eur Urol       Date:  2014-10-31       Impact factor: 20.096

3.  Randomized Study of Systematic Biopsy Versus Magnetic Resonance Imaging and Targeted and Systematic Biopsy in Men on Active Surveillance (ASIST): 2-year Postbiopsy Follow-up.

Authors:  Laurence Klotz; Greg Pond; Andrew Loblaw; Linda Sugar; Madeline Moussa; David Berman; Theo Van der Kwast; Danny Vesprini; Laurent Milot; Marlene Kebabdjian; Neil Fleshner; Sangheet Ghai; Joseph Chin; Masoom Haider
Journal:  Eur Urol       Date:  2019-11-08       Impact factor: 20.096

4.  Predicting Competing Mortality in Patients Undergoing Radical Prostatectomy Aged 70 yr or Older.

Authors:  Michael Froehner; Rainer Koch; Matthias Hübler; Stefan Zastrow; Manfred P Wirth
Journal:  Eur Urol       Date:  2016-10-25       Impact factor: 20.096

5.  Long-term follow-up of a large active surveillance cohort of patients with prostate cancer.

Authors:  Laurence Klotz; Danny Vesprini; Perakaa Sethukavalan; Vibhuti Jethava; Liying Zhang; Suneil Jain; Toshihiro Yamamoto; Alexandre Mamedov; Andrew Loblaw
Journal:  J Clin Oncol       Date:  2014-12-15       Impact factor: 44.544

Review 6.  EAU-EANM-ESTRO-ESUR-SIOG Guidelines on Prostate Cancer-2020 Update. Part 1: Screening, Diagnosis, and Local Treatment with Curative Intent.

Authors:  Nicolas Mottet; Roderick C N van den Bergh; Erik Briers; Thomas Van den Broeck; Marcus G Cumberbatch; Maria De Santis; Stefano Fanti; Nicola Fossati; Giorgio Gandaglia; Silke Gillessen; Nikos Grivas; Jeremy Grummet; Ann M Henry; Theodorus H van der Kwast; Thomas B Lam; Michael Lardas; Matthew Liew; Malcolm D Mason; Lisa Moris; Daniela E Oprea-Lager; Henk G van der Poel; Olivier Rouvière; Ivo G Schoots; Derya Tilki; Thomas Wiegel; Peter-Paul M Willemse; Philip Cornford
Journal:  Eur Urol       Date:  2020-11-07       Impact factor: 20.096

7.  Evaluation of Magnetic Resonance Imaging/Ultrasound-Fusion Biopsy in Patients with Low-Risk Prostate Cancer Under Active Surveillance Undergoing Surveillance Biopsy.

Authors:  Angelika Borkowetz; Theresa Renner; Ivan Platzek; Marieta Toma; Roman Herout; Martin Baunacke; Christer Groeben; Johannes Huber; Michael Laniado; Gustavo B Baretton; Michael Froehner; Stefan Zastrow; Manfred P Wirth
Journal:  Urol Int       Date:  2018-01-16       Impact factor: 2.089

8.  Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.

Authors:  Freddie Bray; Jacques Ferlay; Isabelle Soerjomataram; Rebecca L Siegel; Lindsey A Torre; Ahmedin Jemal
Journal:  CA Cancer J Clin       Date:  2018-09-12       Impact factor: 508.702

9.  Standardized Magnetic Resonance Imaging Reporting Using the Prostate Cancer Radiological Estimation of Change in Sequential Evaluation Criteria and Magnetic Resonance Imaging/Transrectal Ultrasound Fusion with Transperineal Saturation Biopsy to Select Men on Active Surveillance.

Authors:  Svenja Dieffenbacher; Joanne Nyarangi-Dix; Francesco Giganti; David Bonekamp; Claudia Kesch; Maya B Müller-Wolf; Viktoria Schütz; Claudia Gasch; Gencay Hatiboglu; Marcus Hauffe; Albrecht Stenzinger; Stefan Duensing; Heinz-Peter Schlemmer; Caroline M Moore; Markus Hohenfellner; Jan Philipp Radtke
Journal:  Eur Urol Focus       Date:  2019-03-13

10.  Results of a randomized trial of treatment modalities in patients with low or early-intermediate risk prostate cancer (PREFERE trial).

Authors:  Thomas Wiegel; Peter Albers; Detlef Bartkowiak; Roswitha Bussar-Maatz; Martin Härter; Glen Kristiansen; Peter Martus; Stefan Wellek; Heinz Schmidberger; Klaus Grozinger; Peter Renner; Fried Schneider; Martin Burmester; Michael Stöckle
Journal:  J Cancer Res Clin Oncol       Date:  2020-09-04       Impact factor: 4.553
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.